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tYM and alzheiMer’s disease
More testing needed
Although the test your memory (TYM) test 
for detecting Alzheimer’s disease is self 
administered,1 it was given out by clinic staff 
to referred clinic attendees with comparisons 
provided for defined clinical subgroups. The 
people filling in the questionnaires had already 
seen their general practitioner, and were seen 
immediately afterwards by a clinician who 
could address any concerns. The danger of 
calling a test self administered in the title of 
a paper is that it encourages downloading 
from the internet and doing it at home without 
interpretation or support. The diagnosis 
of dementia requires multidisciplinary 
assessement, often over a period of time.2
TYM was administered to a comparatively 
young population (median age under 70) with 
potentially high educational levels; memory 
clinic referrals have not been shown to be 
representative of the general older population. 
TYM’s advantage over the mini mental state 
examination (MMSE) is uncertain as the 
full MMSE receiver operator curve was not 
provided. These factors mean that TYM should 
not be assumed to perform as well in general 
practice waiting rooms or at home. If this is 
the intention for this test it must be applied in 
many different and appropriate settings, with 
longitudinal follow-up to ensure validity, as well 
as appropriate support to those completing it.
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Too many false positives
Brown and colleagues report 93% sensitivity 
and 86% specificity for their self administered 
screening test for Alzheimer’s disease.1 They 
conclude that “it is a powerful and valid 
screening test for the detection of Alzheimer’s 
disease.”
However, doctors and lay people are often 
confused by such conditional probabilities,2 3 
and the value of a screening test is best 
appreciated when statistics are expressed in 
natural frequencies. For infrequent disorders, 
even high values of sensitivity and specificity 
can lead to an unacceptable number of false 
positives.
The accompanying editorial gives an expected 
prevalence of 13 cases of Alzheimer’s disease 
in 1000 people aged 65-69.4 Using this as the 
base rate together with the figures for sensitivity 
and specificity, I calculated test results in natural 
frequencies. For every individual correctly 
declared to have Alzheimer’s disease, about 11, 
on average, will be falsely declared to have this 
dread disease.
This test is likely to become popular among 
doctors and lay people, given its ease of 
administration and the frequency with which 
the important question “Do I have Alzheimer’s?” 
arises. The dissemination of the test would 
be unfortunate because the potential for 
misunderstanding its results is high, and will 
lead to many people incorrectly assessing or 
being told that they have a cruel disorder for 
which there is no hope.
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How specific is TyM?
Is the test your memory (TYM) test specific in 
discriminating Alzheimer’s disease from other 
forms of dementia in clinical practice?1 Only 31 
patients had “other forms of dementia and mild 
cognitive impairment,” 16 having Lewy body 
dementia, 13 frontotemporal dementia, and two 
supranuclear palsy; none had vascular dementia.
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Age profile?
I wondered why Brown and colleagues have 
incorporated so many young people in their 
cross sectional control sample (including 18 
year old volunteers whose risk of Alzheimer’s 
disease is infinitesimal).1 The presence of 
ceiling effects and age effects in the control 
data means that younger people will be more 
likely to score at the top of the scale—and 
the psychometric properties of the test your 
memory (TYM) test could be unwittingly 
distorted by the inclusion of so many junior 
participants.
Older people with presumed Alzheimer’s 
disease tended to score more highly than 
younger people. That older controls tended to 
fare worse than younger people is worrying, 
although the pairwise statistical comparisons 
between age-matched controls and suspected 
Alzheimer’s cases are reassuring. However, cut 
off scores/centile distributions and receiver 
operator characteristic curves would be helpful 
for the age groups at highest risk.
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Diagnoses can be  
meddlesome
Nicholl wrote: “Without a diagnosis, patients and 
carers cannot access the services they need.” 
Echoing the National Dementia Strategy, she 
uses this as justification for early diagnosis of 
dementia.1
We don’t have to organise services in this way. 
Any diagnosis should always require this careful 
judgment: Will giving this label to this person 
at this time do more good than harm? It’s like 
drawing a line in the sand. Diagnosis belongs to 
disease theory and is only one of many ways of 
categorising suffering. The diagnosis of dementia 
has serious implications for the future of a 
family; an early firm diagnosis is often elusive 
and early medical treatments remain marginally 
helpful. If the key early interventions are social 
and emotional support then why medicalise 
early symptoms? They should be socialised 
instead, and the emphasis placed on support 
services. Why make access to these contingent 
on a formal medical diagnosis? In our eagerness 
to do good and to be seen to be doing good, we 
risk drawing our line in the sand in a place that is 
meddlesome.
William House GP commissioner, St Augustine’s Practice, 
Keynsham, Bristol BS31 2BN thehouses@phonecoop.coop
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Authors’ reply
The test your memory (TYM) test is intended to 
be self administered by the patient—allowing 
testing of 10 cognitive skills in minimal 
operator time—but it needs to be overseen and 
interpreted by a health professional.1 The test 
is therefore self administered but not for self 
diagnosis. It is hard to choose an alternative title 
which clarifies this without being too long. As 
a result of the publicity concerning self testing 
we have delayed the launch of the website 
tymtest.com until we can ensure easy access for 
professionals while discouraging self testing.
The TYM test has been validated in a single 
study in a single population presenting with 
cognitive problems, and shows great promise 
as a screening tool in this setting. Problems 
would occur with indiscriminate screening 
of asymptomatic patients, with many false 
positives. We agree that such testing is not 
appropriate. A low TYM score suggests the need 
to look for a cause, it does not mean the patient 
has Alzheimer’s disease. We agree that the TYM 
test needs to be validated in other populations. 
Longitudinal data are crucial and are being 
collected.
The TYM test is not a diagnostic test. The 
diagnosis of Alzheimer’s disease needs a proper 
clinical assessment from a trained professional. 
The TYM test is an aid in this process but not 
a replacement for it. Human beings and brain 
diseases are inherently variable, and a quick 
memory test which would allow an untrained 
person to safely diagnose Alzheimer’s disease 
or distinguish Alzheimer’s disease from other 
forms of degenerative or vascular dementia is 
unlikely ever to exist. An experienced clinician 
may recognise a pattern of scoring on the TYM 
which suggests Alzheimer’s disease or semantic 
dementia in many patients.
We include a wide age range of controls 
because many younger patients have cognitive 
complaints as a result of epilepsy, multiple 
sclerosis, and other conditions, and we believe 
the TYM test may be useful in these patients. The 
average TYM scores of controls are remarkably 
stable but do fall off after the age of 70, as do 
most similar tests. There were no significant 
differences between older and younger patients 
with Alzheimer’s disease.
We are well aware of the ethical debate around 
early diagnosis of Alzheimer’s disease and 
share many of the concerns of correspondents. 
Progress towards early diagnosis must be made 
for several reasons. If a treatment that halts 
Alzheimer’s disease becomes available, we need 
a test to identify those likely to benefit.
Jeremy Brown consultant neurologist  
jmb75@medschl.cam.ac.uk 
George Pengas clinical research fellow 
Kate Dawson research nurse 
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Philip Clatworthy clinical research fellow, Department of 
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interrogation of detainees
Physicians have been involved
In 2007 I was invited to examine the detainee log 
of an inmate of Guantanamo to provide a medical 
opinion on whether the treatment amounted to 
torture.1 It has now been concluded that it did.2
My scrutiny found that medical staff not 
only were present during the interrogation but 
also made no attempt to intervene to stop it. A 
military radiologist was even flown in to report 
on a computed tomogram taken when the 
detainee became seriously dehydrated from 
hunger strike. Newly declassified legal memos 
from 2002 and 2005 concluded that certain 
“enhanced interrogation techniques” did not 
constitute torture, partly based on the assurance 
that medical personnel would be on hand to 
ensure that the techniques used did not cause 
“severe pain or suffering.”3 The Red Cross report 
leaked in April details the involvement of medical 
personnel present at and supplying medical 
interventions during the use of these enhanced 
techniques, some of which it describes as 
torture.4
This seems clear evidence that military 
medical personnel acted in contravention to the 
Declaration of Tokyo that a “physician shall not 
be present during any procedure during which 
torture or any other forms of cruel, inhuman or 
degrading treatment is used or threatened.” 
I do not therefore understand how Pope and 
Gutheil can assert that “physicians limited their 
involvement in detainee interrogations to such a 
degree that they prohibited even monitoring an 
interrogation with intent to intervene” and that 
“physicians do not design interrogation plans for 
specific detainees or observe interrogations with 
the intent to intervene because this undermines 
the physician’s role as healer.”5
Physicians have no grounds to feel superior to 
psychologists: to date, no US military physician 
has had a licence to practise revoked as a 
consequence of their involvement, whatever the 
policies of the American Medical Association.
Abigail Seltzer consultant psychiatrist, health and human rights 
adviser, Medical Foundation for the Care of Victims of Torture, 
london N7 7JW aseltzer@torturecare.org.uk
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Authors’ reply
We appreciate Seltzer’s thoughtful comments.1 
In our article “Contrasting ethical policies 
of physicians and psychologists concerning 
interrogation of detainees,” we examined 
the ethical policies of the American Medical 
Association (AMA) and American Psychological 
Association (APA).2 What Seltzer describes as our 
erroneous conclusions are our restatement of 
AMA’s formal ethical policy.
For example, Seltzer quotes us as saying 
“physicians do not  . . . observe interrogations 
with the intent to intervene because this 
undermines the physician’s role as healer.” 
However, we wrote: “Priscilla Ray, chair of the 
American Medical Association (AMA) council on 
ethical and judicial affairs, stated: ‘Physicians 
must not conduct, directly participate in, 
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the symptoms are generally non-specific, 
general practitioners can identify a significant 
proportion of women requiring investigation. In 
the GP records of a recent cohort from Devon, 
soon to be published in the BMJ, 196 of the 
212 women with primary ovarian cancer had 
either a symptom recorded or a mass noted 
before diagnosis. Eighty eight were referred 
for investigation on the same day as the first 
symptom was recorded, with a further 36 within 
the next week. This leaves a minority of women 
who experience diagnostic delays in primary care 
and who would benefit from a lowering of the 
threshold for investigation.
However, the performance of CA125 
measurement has not been studied in 
primary care. In a recent UK screening trial 
8.6% of women had an initially raised CA125 
concentration.4 Most of them had normal results 
on repeat testing, but in the low prevalence 
setting of primary care many false positive 
results would be generated for each true 
positive. The potential adverse effects of a false 
positive result for ovarian cancer are not only 
the emotional considerations but also the risk of 
biopsy, or even oophrectomy, to achieve peace 
of mind. False positive results on ultrasound 
scanning were less common in the screening 
trial, so ultrasonography should remain the 
preferred investigation in primary care.
William Hamilton general practitioner and consultant senior 
lecturer, University of Bristol, Bristol BS8 2AA  
w.hamilton@bristol.ac.uk 
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institutional safetY probleM
Where is the NHS  
Macpherson?
Macpherson found an institutional problem of 
racism in the Metropolitan Police. The NHS seems 
to have an institutional problem about safety. 
Surely the failure of all the safety mechanisms at 
local, regional, and national levels in Staffordshire 
demand wider investigation than the narrow 
focus on the trust by the select committee, and 
the anecdotal approach of a recent conference.1 2
That the responsible heads of the NHS suggest 
juniors should “make waves” seems superficial. 
Senior medical and nursing staff at Stafford tried 
to make waves, and were not heard. It is surely 
not for the trust and its staff alone to “stand up 
for safety.” What was happening at the primary 
care trust, which commissioned health care 
from the trust and should have been listening to 
the community and the staff? Did it not hear or 
see the waves? Perhaps the local MP has a role 
in ensuring safe health care for constituents. 
Is safety of no concern to the strategic health 
authority? Monitor should have a broader view 
of performance than purely financial issues, 
and the Health Care Commission itself seems to 
have been slow to recognise problems that were 
common knowledge and of concern to medical 
and nursing staff. A lot of waves were made, but 
no one in the organisation with responsibility for 
oversight was able to see or hear them.
The organisation as a whole seems not to have 
a systemic approach that makes safety a priority. 
Unlike flying, health care cannot be made entirely 
risk free, but present approaches seem to verge 
on the futile. The chief medical officer reported 
high risks of a fatal outcome, but in five years 
seems to have been unable to do anything about 
a potentially fatal hazard in drug administration. 
At these accident rates, the NHS’s performance 
would surely be regarded as unacceptable if it 
was responsible for running an airline. Airbus 
and Boeing would be expected to respond more 
promptly to a design issue.
The NHS, a significant customer, seems unable 
to exert any power as a commissioner. We need 
to look further than the problems of what was 
clearly an over-ambitious trust. Encouraging 
junior doctors to raise concerns is laudable, but it 
may take attention away from more fundamental 
issues. We need something better from our 
commissioners and higher management.
Martin W McNicol retired physician and health authority and 
trust chairman, Beverley HU17 8HP  
mcnicol1@mcnicol1.karoo.co.uk
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or monitor an interrogation with an intent 
to intervene, because this undermines the 
physician’s role as healer.’”
Physicians who conducted, directly 
participated in, or monitored an interrogation 
with an intent to intervene violated AMA’s explicit 
ethical prohibition.
APA’s ethical policies differed significantly. 
As our article documented, APA claimed that 
psychologists, unlike physicians, were uniquely 
qualified for this work, “knew not to participate 
in activities that harmed detainees,” and were 
contributing to national security.
Works appearing after our article’s publication 
provide additional documentation of how 
APA’s ethical policies supported psychologists’ 
extensive, integral roles in interrogations. One 
example is the 10 minute documentary “No Place 
to Hide: Torture, Psychologists, and the APA.”3
Another example is the open letter to the 
APA from Amnesty International, Physicians for 
Human Rights, and 11 other organisations.4 The 
letter describes necessary steps to address “the 
terrible stain on  . . . American psychology.” Here 
is an excerpt:
Any meaningful approach to this issue 
must start by acknowledging the fact that 
psychologists were absolutely integral. . . 
When the Bush administration decided 
to engage in torture, they turned to 
psychologists  . . .  APA leadership has 
much work ahead to begin to repair the 
harm they have caused to the profession, 
the country, former and current detainees 
and their families.
Kenneth S Pope independent licensed psychologist, PO Box 
777, Norwalk, CT 06856-0777, USA kspope@mac.com 
Thomas G Gutheil professor of psychiatry, Beth Israel 
Deaconess Medical Center, Harvard Medical School, 
Brookline, MA 02446, USA
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ovarian cancer
Not a silent killer
When will ovarian cancer stop being called 
the silent killer?1 If it were truly silent, general 
practitioners could hardly be blamed for 
missing it. It is far from silent: its noise is 
difficult to interpret.
Recent studies of newly diagnosed women 
show that symptoms are common and 
reported to general practitioners.2 3 Although 
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incidental lYMphocYtosis
Cancer targets not as  
rational as testing
Grove and colleagues advise general practitioners 
how to manage asymptomatic patients with 
incidental lymphocytosis and ultimately chronic 
lymphatic leukaemia, recommending repeat 
blood counts at 2-4 weeks and 3 months and 
then referral to a haematology clinic.1
This rational testing does not sit comfortably 
with the less rational cancer waiting times target 
that patients with a suspicion of cancer should 
be seen within 15 days.2 The suspicion of cancer 
in this case was extremely high from the outset 
but did not warrant urgent referral. Asymptomatic 
patients with monoclonal gammopathy are 
a similar example. These examples highlight 
ongoing clinical concerns with all inclusive 
cancer targets.
The lead cancer clinicians for the west of 
Scotland have expressed their concerns that 
cancer targets come both with a clinical cost 
and at the expense of audit of treatment and 
outcome.3 Yet clinical audit underpins cancer 
networks and is the key to service improvement. 
The delivery of cancer services should be 
refocused on the results of clinical audit rather 
than the ever increasing demands of targets.
edward Fitzsimons consultant haematologist, Western 
Infirmary, Glasgow G11 6NT  
edward.fitzsimons@ggc.scot.nhs.uk 
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Blood Cancer Managed Clinical Network, Glasgow Royal 
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suMMarY care records
No enrichment without consent
The Royal College of General Practitioners 
now seems to support the summary care 
record.1 As a college member, I am concerned 
Sitting leaders ask you  
to stand up for safety
If junior doctors follow the recommendation of 
medical leaders and stand up for the safety of 
patients will they receive support from those 
leaders?1
“Staff concerns about safety at Mid 
Staffordshire trust were ‘lost in a black hole.’”2 
The evidence suggests that whistleblowers 
who report concerns are treated no better in 
the NHS now than at the time of the scandal 
at Bristol Royal Infirmary.3 Medical leaders are 
responsible for the culture of silence. To become 
a medical leader one needs to compromise 
principles for expediency to meet the demands 
of politicians (in an organisation or government) 
with the power to advance or destroy a career. 
Medical leaders lack moral authority because 
few of them have taken the risk of speaking 
out on their way to the top. They are too often 
complicit in concealment of problems to protect 
their organisations or political masters.4
Fiona Godlee spoke at the conference and 
represented the BMJ.1 The BMJ has removed 
from its website articles that have appeared 
in the paper journal purely to avoid the risk of 
the journal being sued for libel. The articles 
have not been retracted because there are no 
grounds for retraction of truthful reports. Does 
the BMJ want junior doctors to take the risk of 
losing their careers by speaking out when it is 
afraid of the financial cost of speaking?
Liam Donaldson also spoke at the 
conference.1 I have had correspondence and 
meetings with the chief medical officer to 
discuss misconduct by doctors, but I am left 
with the impression that he is unwilling or 
unable to act when the allegations involve 
senior medical leaders. Yet Sir Liam wants junior 
doctors to be brave enough to speak about 
problems.
The motivational speeches of medical leaders 
to junior doctors seem to be like the pep talks 
of generals to soldiers at the Somme before 
the troops went over the top and the leaders 
returned to their chateau for lunch. Medical 
leaders must now lead from the front and share 
the risks.
Peter T Wilmshurst consultant cardiologist, Royal 
Shrewsbury Hospital, Shrewsbury SY3 8XQ  
peter.wilmshurst@tiscali.co.uk
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that it may not have dealt comprehensively 
with enrichment—the addition of important 
information such as a disease summary, 
drug treatments, and allergies to the record. 
Bolton local medical committee opposes the 
enrichment of summary care records without 
explicit patient consent because of concerns 
about confidentiality.2
Patients need to know what is happening 
to their data. Let them decide. No enrichment 
without explicit patient consent.
Chris Woods general practitioner, Bolton Bl1 3RG 
christopher.woods@gp-p82022.nhs.uk
Competing interests: None declared.
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Time for continuity of record
Most lay people assume that the NHS is a 
national health outfit that works together to 
look after them. They do not appreciate its 
tribal nature, with warring factions unwilling 
to communicate vital information about drugs 
and allergies to fellow health professionals. It is 
time we dragged ourselves into the 21st century 
communications age.1 General practitioners 
no longer work 24 hours a day 7 days a week 
doing their personal on call. Continuity of the 
patient record is needed now that we do not have 
continuity of personal care.
Jonathan M orrell general practitioner,  
Weymouth DT4 7BY jon.orrell@nhs.net
Competing interests: JMO is MRCGP clinical lead, NHS Dorset.
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Joy of shared health records
The summary care record is a step towards 
a truly shared health record away from the 
fragmented jumble of paper and partially 
computerised records in most of the NHS.1 
This area has been using shared records for a 
decade. I can view what has happened to my 
patients when they are seen by my colleagues 
working out of hours, in palliative care teams, in 
community nursing, and medical outpatients. 
More importantly these colleagues have access 
to the information that enables them to do their 
job more safely and efficiently. Most importantly 
my patients get better care, and they know it.
Matthew Curtis GP partner, Holycroft Surgery, Keighley 
BD21 1SA mattcurtis@doctors.org.uk
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Bradford and Airedale.
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